Clinical Trials Directory

Trials / Completed

CompletedNCT05551364

Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy

Usabilidad y Efectividad Del Exoesqueleto ATLAS2030 en Variables físicas, Emocionales y Funcionales en niños Con parálisis Cerebral

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
MarsiBionics · Industry
Sex
All
Age
3 Years – 14 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to assess the usability and efficacy of receiving therapy with the peaditric exoskeleton ATLAS 2030in children with gait impairment due to a cerebral palsy condition. It will be valued the impact of rehabilitation with the exoskeleton at the physical level on parameters such as joint range, spasticity, as well as the impact in quality of life. It is also assessed the impact at the level of functionality of the participants, through the administration of different functional assessment scales.

Conditions

Interventions

TypeNameDescription
DEVICEATLAS 2030 exoskeletonIndividualized Rehabilitation Treatment with the ATLAS 2030 Exoskeleton consists of the following phases: 1. Telephone contact phase (1 session) 2. Inclusion Phase (1 session) 3. Signing of informed consent (1 session) 4. Initial Evaluation Phase (1 session) 5. Treatment Phase (1st part) (7 sessions) 6. Monthly Evaluation Phase (1 session) 7. Treatment Phase (2nd part) (7 sessions) 8. Monthly Evaluation Phase (1 session) 9. Treatment Phase (3rd part) (7 sessions) 10. Final Evaluation Phase and results (2 sessions)

Timeline

Start date
2022-09-05
Primary completion
2023-06-02
Completion
2023-08-30
First posted
2022-09-22
Last updated
2024-09-27

Locations

6 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT05551364. Inclusion in this directory is not an endorsement.